Frailty-adjusted therapy in Transplant Non-Eligible patients with newly diagnosed Multiple Myeloma (FiTNEss (UK-MRA Myeloma XIV Trial)): a study protocol for a randomised phase III trial

INTRODUCTION: Multiple myeloma is a bone marrow cancer, which predominantly affects older people. The incidence is increasing in an ageing population. Over the last 10 years, patient outcomes have improved. However, this is less apparent in older, less fit patients, who are ineligible for stem cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Coulson, Amy Beth, Royle, Kara-Louise, Pawlyn, Charlotte, Cairns, David A, Hockaday, Anna, Bird, Jennifer, Bowcock, Stella, Kaiser, Martin, de Tute, Ruth, Rabin, Neil, Boyd, Kevin, Jones, John, Parrish, Christopher, Gardner, Hayley, Meads, David, Dawkins, Bryony, Olivier, Catherine, Henderson, Rowena, Best, Phillip, Owen, Roger, Jenner, Matthew, Kishore, Bhuvan, Drayson, Mark, Jackson, Graham, Cook, Gordon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Haematology (Incl Blood Transfusion)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163533/
https://www.ncbi.nlm.nih.gov/pubmed/35654466
http://dx.doi.org/10.1136/bmjopen-2021-056147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163533/
https://www.ncbi.nlm.nih.gov/pubmed/35654466
http://dx.doi.org/10.1136/bmjopen-2021-056147

Ejemplares similares